Copyright
©2014 Baishideng Publishing Group Inc.
World J Transplant. Dec 24, 2014; 4(4): 294-298
Published online Dec 24, 2014. doi: 10.5500/wjt.v4.i4.294
Published online Dec 24, 2014. doi: 10.5500/wjt.v4.i4.294
Table 1 Pediatric patients transplanted for hepatoblastoma at our center before (Era 1) and after (Era 2) implementation of pediatric end-stage liver disease exception points for hepatoblastoma
| Era 1 (1987-2009) | Era 2 (2010-2014) | Significance (P-value) | |
| Total patients listed for transplantation | 7 | 14 | 0.189 |
| Gender | 0.557 | ||
| Male | 57.10% | 35.70% | |
| Female | 42.90% | 64.30% | |
| Age at listing (yr) | 5.4 | 2 | 0.094 |
| Age at transplant (yr) | 5.6 | 2.1 | 0.110 |
| Waitlist time (d) | 45.6 | 25.4 | 0.025 |
- Citation: Khaderi S, Guiteau J, Cotton RT, O’Mahony C, Rana A, Goss JA. Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant 2014; 4(4): 294-298
- URL: https://www.wjgnet.com/2220-3230/full/v4/i4/294.htm
- DOI: https://dx.doi.org/10.5500/wjt.v4.i4.294